
The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 vaccine, but only for certain people. The vaccine is now approved for adults ages 65 and older, or for people ages 12 to 64 who have at least one health condition that puts them at higher risk of serious illness from… read on > read on >